Memo Therapeutics AG is an innovator in the field of antibody discovery and immune repertoire analysis.

Cooperation possibilities

The company is developing a proprietary antibody pipeline in infectious diseases, immuno-oncology and is engaged in human antibody repertoire analysis. Memo Therapeutics is collaborating with partners for antibody discovery and immune repertoire analysis.

Location

Wagistrasse 27, 8952 Schlieren, Switzerland

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2012
  • Number of employees in Switzerland
    1-9
Key business